Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Vivos Therapeutics, Inc. issued a pre-funded warrant to purchase 429,957 shares of Common Stock (the " Pre-Funded Warrant "), (iii) a Series A Common Stock Purchase Warrant (the " Series A War of warrant to V-Co Investors 3 LLC for purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants.
- Security
- warrant
- Shares
- a pre-funded warrant to purchase 429,957 shares of Common Stock (the " Pre-Funded Warrant "), (iii) a Series A Common Stock Purchase Warrant (the " Series A War
- Purchaser
- V-Co Investors 3 LLC
- Consideration
- purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants
Exact text from the filing
“ Warrants ”, and with the shares of Common Stock underlying the Common Stock Purchase Warrants being referred to as the “ Warrant Shares ”). V-Co 3 paid a purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants, with such price being established for purposes of compliance with the listing rules
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Vivos Therapeutics, Inc. issued 1,353,625 shares (the "PIPE Shares") of Common Stock of common stock to V-Co Investors 3 LLC for purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants.
- Security
- common stock
- Shares
- 1,353,625 shares (the "PIPE Shares") of Common Stock
- Purchaser
- V-Co Investors 3 LLC
- Consideration
- purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants
Exact text from the filing
“ Warrants ”, and with the shares of Common Stock underlying the Common Stock Purchase Warrants being referred to as the “ Warrant Shares ”). V-Co 3 paid a purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants, with such price being established for purposes of compliance with the listing rules
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Vivos Therapeutics, Inc. entered into Securities Purchase Agreement with V-Co Investors 3 LLC valued at $850,000 cash proceeds; $1,400,000 conversion of bridge note; total purchase price $1.34 per share (effective 2026-03-31).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- V-Co Investors 3 LLC
- Value
- $850,000 cash proceeds; $1,400,000 conversion of bridge note; total purchase price $1.34 per share
- Effective
- 2026-03-31
Exact text from the filing
On March 31, 2026, Vivos Therapeutics, Inc., a Delaware corporation (the “ Company ”) entered into a Securities Purchase Agreement (the “ PIPE SPA ”) with V-Co Investors 3 LLC, a Wyoming limited liability company (“ V-Co 3 ”).
View on SEC.gov